title: Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery.
authors: Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA.
authors: Jongjin
authors: J
authors: Jung
authors: Aniruddh
authors: A
authors: Solanki
authors: Kevin A
authors: KA
authors: Memoli
authors: Ken-ichiro
authors: K
authors: Kamei
authors: Hiyun
authors: H
authors: Kim
authors: Michael A
authors: MA
authors: Drahl
authors: Lawrence J
authors: LJ
authors: Williams
authors: Hsian-Rong
authors: HR
authors: Tseng
authors: KiBum
authors: K
authors: Lee
mesh_terms: D017209:Apoptosis; D001932:Brain Neoplasms / Q000378:metabolism / Q000628:therapy*; D045744:Cell Line, Tumor; D066246:ErbB Receptors / Q000235:genetics / Q000378:metabolism; D055785:Gene Knockdown Techniques; D006801:Humans; D009842:Oligopeptides / Q000737:chemistry / Q000378:metabolism; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D045663:Quantum Dots; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000378:metabolism*; D015398:Signal Transduction; D054322:tat Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000378:metabolism
chemical_list: D009842:Oligopeptides; D034741:RNA, Small Interfering; C410723:epidermal growth factor receptor VIII; D054322:tat Gene Products, Human Immunodeficiency Virus; C047981:arginyl-glycyl-aspartic acid; D019869:Phosphatidylinositol 3-Kinases; D066246:ErbB Receptors; D051057:Proto-Oncogene Proteins c-akt